Calamos Advisors LLC lessened its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 12.5% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 465,936 shares of the healthcare conglomerate’s stock after selling 66,340 shares during the quarter. UnitedHealth Group makes up about 0.7% of Calamos Advisors LLC’s investment portfolio, making the stock its 26th largest position. Calamos Advisors LLC’s holdings in UnitedHealth Group were worth $91,254,000 at the end of the most recent reporting period.
Several other large investors have also recently made changes to their positions in UNH. Blue Chip Partners Inc. bought a new position in UnitedHealth Group in the 2nd quarter valued at $110,000. Bruderman Asset Management LLC bought a new position in UnitedHealth Group in the 2nd quarter valued at $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. raised its position in UnitedHealth Group by 433.3% in the 2nd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock valued at $119,000 after purchasing an additional 520 shares during the last quarter. BDO Wealth Advisors LLC bought a new position in UnitedHealth Group in the 2nd quarter valued at $121,000. Finally, Kings Point Capital Management raised its position in UnitedHealth Group by 27.9% in the 1st quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock valued at $113,000 after purchasing an additional 150 shares during the last quarter. 85.97% of the stock is currently owned by institutional investors.
Several equities analysts have issued reports on the company. Wells Fargo & Co reiterated an “outperform” rating and issued a $245.00 price objective (up previously from $230.00) on shares of UnitedHealth Group in a research report on Wednesday, November 29th. Leerink Swann reiterated an “outperform” rating on shares of UnitedHealth Group in a research report on Friday, December 1st. BMO Capital Markets assumed coverage on UnitedHealth Group in a research report on Monday, October 16th. They issued an “outperform” rating and a $250.00 price objective for the company. Citigroup lifted their price objective on UnitedHealth Group from $213.00 to $235.00 and gave the company a “buy” rating in a research report on Wednesday, October 18th. Finally, Jefferies Group reiterated a “buy” rating and issued a $248.00 price objective on shares of UnitedHealth Group in a research report on Friday, December 1st. Three analysts have rated the stock with a hold rating and twenty-four have assigned a buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus price target of $224.56.
Shares of UnitedHealth Group Incorporated (UNH) opened at $220.00 on Monday. The firm has a market capitalization of $211,090.00, a price-to-earnings ratio of 25.00, a PEG ratio of 1.65 and a beta of 0.66. UnitedHealth Group Incorporated has a 52-week low of $156.09 and a 52-week high of $231.77. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.70 and a current ratio of 0.70.
UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share for the quarter, topping analysts’ consensus estimates of $2.57 by $0.09. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The company had revenue of $50.32 billion during the quarter, compared to the consensus estimate of $50.38 billion. During the same quarter in the previous year, the company posted $2.17 earnings per share. The firm’s quarterly revenue was up 8.7% on a year-over-year basis. research analysts forecast that UnitedHealth Group Incorporated will post 9.99 EPS for the current year.
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 12th. Investors of record on Friday, December 1st were paid a dividend of $0.75 per share. The ex-dividend date of this dividend was Thursday, November 30th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.36%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 34.09%.
COPYRIGHT VIOLATION WARNING: This news story was originally posted by Community Financial News and is the sole property of of Community Financial News. If you are reading this news story on another domain, it was illegally stolen and republished in violation of U.S. & international copyright legislation. The original version of this news story can be read at https://www.com-unik.info/2017/12/25/calamos-advisors-llc-sells-66340-shares-of-unitedhealth-group-incorporated-unh.html.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.